Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

IFN-γ (+874) and not TNF-α (-308) is associated with HBV-HCC risk in India.

Saxena R, Chawla YK, Verma I, Kaur J.

Mol Cell Biochem. 2014 Jan;385(1-2):297-307. doi: 10.1007/s11010-013-1838-9.

PMID:
24101445
2.

IL-6(-572/-597) polymorphism and expression in HBV disease chronicity in an Indian population.

Saxena R, Chawla YK, Verma I, Kaur J.

Am J Hum Biol. 2014 Jul-Aug;26(4):549-55. doi: 10.1002/ajhb.22562.

PMID:
24841049
3.

Interleukin-1 polymorphism and expression in hepatitis B virus-mediated disease outcome in India.

Saxena R, Chawla YK, Verma I, Kaur J.

J Interferon Cytokine Res. 2013 Feb;33(2):80-9. doi: 10.1089/jir.2012.0093.

PMID:
23210983
4.

Effect of IL-12B, IL-2, TGF-β1, and IL-4 polymorphism and expression on hepatitis B progression.

Saxena R, Chawla YK, Verma I, Kaur J.

J Interferon Cytokine Res. 2014 Feb;34(2):117-28. doi: 10.1089/jir.2013.0043.

PMID:
24161121
5.

Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma.

Migita K, Miyazoe S, Maeda Y, Daikoku M, Abiru S, Ueki T, Yano K, Nagaoka S, Matsumoto T, Nakao K, Hamasaki K, Yatsuhashi H, Ishibashi H, Eguchi K.

J Hepatol. 2005 Apr;42(4):505-10.

PMID:
15763337
6.

The relationship between TNF alpha gene polymorphisms (-238/-308), TNF RII VNTR (p75) and outcomes of hepatitis B virus infection in Tunisian population.

Sghaier I, Zidi S, Mouelhi L, Dabbech R, Ghazouani E, Brochot E, Stayoussef M, Yacoubi-Loueslati B.

Gene. 2015 Sep 1;568(2):140-5. doi: 10.1016/j.gene.2015.05.029.

PMID:
25982858
7.

Alleles and genotypes of polymorphisms of IL-18, TNF-α and IFN-γ are associated with a higher risk and severity of hepatocellular carcinoma (HCC) in Brazil.

Teixeira AC, Mendes CT Jr, Marano LA, Deghaide NH, Secaf M, Elias J Jr, Muglia V, Donadi EA, Martinelli AL.

Hum Immunol. 2013 Aug;74(8):1024-9. doi: 10.1016/j.humimm.2013.04.029.

PMID:
23632060
8.

Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.

Li S, Deng Y, Chen ZP, Huang S, Liao XC, Lin LW, Li H, Peng T, Qin X, Zhao JM.

Infect Genet Evol. 2011 Dec;11(8):2083-8. doi: 10.1016/j.meegid.2011.09.025.

PMID:
22019522
9.
10.

-509C>T polymorphism in the TGF-beta1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection.

Qi P, Chen YM, Wang H, Fang M, Ji Q, Zhao YP, Sun XJ, Liu Y, Gao CF.

Cancer Immunol Immunother. 2009 Sep;58(9):1433-40. doi: 10.1007/s00262-009-0660-4.

PMID:
19169878
12.

Association of interleukin-10 with hepatitis B virus (HBV) mediated disease progression in Indian population.

Saxena R, Chawla YK, Verma I, Kaur J.

Indian J Med Res. 2014 May;139(5):737-45.

13.

Altered TNF-α and IFN-γ levels associated with PD1 but not TNFA polymorphisms in patients with chronic HBV infection.

Zhang G, Li Z, Han Q, Li N, Zhu Q, Li F, Lv Y, Chen J, Lou S, Liu Z.

Infect Genet Evol. 2011 Oct;11(7):1624-30. doi: 10.1016/j.meegid.2011.06.004.

PMID:
21712100
14.

Tumor necrosis factor-alpha -308G/A polymorphism and risk of hepatocellular carcinoma in hepatitis C virus-infected patients.

Talaat RM, Esmail AA, Elwakil R, Gurgis AA, Nasr MI.

Chin J Cancer. 2012 Jan;31(1):29-35. doi: 10.5732/cjc.011.10258.

15.

A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection.

Zhu ZZ, Cong WM, Liu SF, Xian ZH, Wu WQ, Wu MC, Gao B, Hou LF, Zhu GS.

Cancer Lett. 2005 Nov 8;229(1):77-83.

PMID:
15979781
16.

Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.

Motawi TK, Shaker OG, Ismail MF, Sayed NH.

Gene. 2013 Sep 25;527(2):516-20. doi: 10.1016/j.gene.2013.06.053.

PMID:
23845776
17.

Associations between cytotoxic T lymphocyte-associated antigen-4 polymorphisms and serum tumor necrosis factor-α and interferon-γ levels in patients with chronic hepatitis B virus infection.

Han Q, Duan S, Zhang G, Li Z, Li N, Zhu Q, Lv Y, Chen J, Liu Z.

Inflamm Res. 2011 Nov;60(11):1071-8. doi: 10.1007/s00011-011-0368-8.

PMID:
21847627
18.

Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients.

Li Y, Xie Q, Lu F, Zhao J, Mao P, Li Z, Liu S, Zhuang H.

Liver Int. 2010 Jan;30(1):112-8. doi: 10.1111/j.1478-3231.2009.02134.x.

PMID:
19840254
19.

Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma.

Chen CC, Yang SY, Liu CJ, Lin CL, Liaw YF, Lin SM, Lee SD, Chen PJ, Chen CJ, Yu MW.

Int J Epidemiol. 2005 Dec;34(6):1310-8.

PMID:
16172101
20.

Genetic polymorphisms in hypoxia-inducible factor-1a gene and its association with HBV-related hepatocellular carcinoma in a Chinese population.

Liu Y, Sui J, Zhai L, Yang S, Huang L, Huang L, Mo C, Wu J, Li S, Qin X.

Med Oncol. 2014 Oct;31(10):200. doi: 10.1007/s12032-014-0200-8.

PMID:
25195037

Supplemental Content

Support Center